Certified by Founder Lodge
GC Cell
Korea, Republic Of - Yongin-si, Gyeonggi-do
INVESTOR
1 Disclosed Funding Rounds $16,500,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
GC Cell has various pipelines based on NK, T, and stem cells. GC Cell has excellent research capabilities and global-level cell therapy products based on solid platform technology from initia
| Company | Date | Round | Raised |
|---|---|---|---|
 Feldan Therapeutics |
June, 14 ,2023 | Series B | $16,500,000 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Datatruck | $12,000,000 | (Jan 29, 2026)
Scholé AI | $3,000,000 | (Jan 29, 2026)
Tenbin Labs | $7,000,000 | (Jan 29, 2026)
Adaptive6 | $28,000,000 | (Jan 29, 2026)
Vention | $110,000,000 | (Jan 29, 2026)
